|
| Exchange Disseminated Time 05/01/2017 11:45:58 | Cadila Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on January 31, 2017 to consider inter alia, to approve the un-audited financial results for the quarter / nine months ended on December 31, 2016 (Q3).
Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from January 05, 2017 to February 02, 2017 (both days inclusive) for all the connected persons. |
|
|